{"schema_version":"1","generated_at":"2026-10-28T18:07:28.838Z","data_as_of":null,"url":"https://www.findmykol.com/kol/mark-buyyounouski","json_url":"https://www.findmykol.com/kol/mark-buyyounouski/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"mark-buyyounouski","name":"Mark Buyyounouski","credential":"MD","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Stanford Medicine","institution_url":"https://www.findmykol.com/institution/stanford-university-school-of-medicine","city":"Stanford","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1912927021","orcid":"0000-0001-9294-9421","openalex":"A5023976830"},"summary":"Mark Buyyounouski is an Oncology physician affiliated with Stanford Medicine. OpenAlex indexes 316 publications with 9,874 citations (h-index 50); ClinicalTrials.gov lists 3 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":316,"cited_by_count":9874,"h_index":50,"latest_activity_year":2024,"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT03274687","title":"Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer","phase":"PHASE3","status":"COMPLETED","role":"Overall official","sponsor":"NRG Oncology","source_url":"https://clinicaltrials.gov/study/NCT03274687","trial_url":"https://www.findmykol.com/trial/NCT03274687"},{"nct":"NCT02346253","title":"High-Dose Brachytherapy in Treating Patients With Prostate Cancer","phase":"NA","status":"COMPLETED","role":"Overall official","sponsor":"Stanford University","source_url":"https://clinicaltrials.gov/study/NCT02346253","trial_url":"https://www.findmykol.com/trial/NCT02346253"},{"nct":"NCT00062309","title":"Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate Cancer","phase":"PHASE3","status":"COMPLETED","role":"Overall official","sponsor":"Fox Chase Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT00062309","trial_url":"https://www.findmykol.com/trial/NCT00062309"}],"source":"trials"},"prescribing":{"data_year":2024,"areas_total":2,"areas_shown":2,"areas":[{"area":"Genitourinary & hormones","share_pct":58,"classes_total":1,"classes":[{"class":"alpha-Adrenergic Blocker","setting":"prescribed","share_pct":58,"drugs":[{"name":"Tamsulosin Hcl","share_pct":100}],"max_beneficiaries":23}]},{"area":"Metabolism & gastrointestinal","share_pct":42,"classes_total":1,"classes":[{"class":"H2 blocker","setting":"prescribed","share_pct":42,"drugs":[{"name":"Famotidine","share_pct":100}],"max_beneficiaries":19}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0.8,"facility_pct":99.2},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Bladder Cancer, Version 3.2024","year":2024,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2024.0024","status":"verified"},{"title":"Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy","year":2024,"journal":"The Journal of Urology","source_url":"https://doi.org/10.1097/ju.0000000000003892","status":"verified"},{"title":"NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022","year":2022,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2022.0041","status":"verified"},{"title":"PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer","year":2021,"journal":"Journal of Nuclear Medicine","source_url":"https://doi.org/10.2967/jnumed.120.259630","status":"verified"},{"title":"Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology","year":2020,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2020.0011","status":"verified"}],"source":"works"},"contact":{"address_1":"300 PASTEUR DR","city":"Stanford","state":"CA","zip":"943052200","phone":"650-723-4000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1912927021","source":"identity"},"similar":[{"name":"Jeffrey Teuteberg","slug":"jeffrey-teuteberg","institution":"Stanford Medicine","specialty":"Advanced Heart Failure and Transplant Cardiology","url":"https://www.findmykol.com/kol/jeffrey-teuteberg","json_url":"https://www.findmykol.com/kol/jeffrey-teuteberg/profile.json"},{"name":"Charles Debattista","slug":"charles-debattista","institution":"Stanford Medicine","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/charles-debattista","json_url":"https://www.findmykol.com/kol/charles-debattista/profile.json"},{"name":"Michael Amylon","slug":"michael-amylon","institution":"Stanford Medicine","specialty":"Pediatric Hematology-Oncology","url":"https://www.findmykol.com/kol/michael-amylon","json_url":"https://www.findmykol.com/kol/michael-amylon/profile.json"},{"name":"Kimberly Dequattro","slug":"kimberly-dequattro","institution":"Stanford Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/kimberly-dequattro","json_url":"https://www.findmykol.com/kol/kimberly-dequattro/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2016-04-01","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}